TY - JOUR
T1 - HIV Testing and Diagnosis Rates in Kiev, Ukraine
T2 - April 2013-March 2014
AU - Simmons, Ruth
AU - Malyuta, Ruslan
AU - Chentsova, Nelli
AU - Medoeva, Antonia
AU - Kruglov, Yuri
AU - Yurchenko, Alexander
AU - Copas, Andrew
AU - Porter, Kholoud
AU - CASCADE collaboration in EuroCoord
A2 - Lundgren, Jens Dilling
PY - 2015
Y1 - 2015
N2 - OBJECTIVE: Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates.METHODS: As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (≥16 yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev.RESULTS: During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6 to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners.CONCLUSION: Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures.
AB - OBJECTIVE: Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates.METHODS: As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (≥16 yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev.RESULTS: During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6 to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners.CONCLUSION: Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures.
KW - Acquired Immunodeficiency Syndrome/diagnosis
KW - Adolescent
KW - Adult
KW - Female
KW - HIV Infections/diagnosis
KW - Heterosexuality/psychology
KW - Homosexuality, Male/psychology
KW - Humans
KW - Incidence
KW - Male
KW - Mass Screening/methods
KW - Risk Factors
KW - Risk-Taking
KW - Sexual Partners/psychology
KW - Ukraine/epidemiology
KW - Young Adult
U2 - 10.1371/journal.pone.0137062
DO - 10.1371/journal.pone.0137062
M3 - Journal article
C2 - 26322977
SN - 1932-6203
VL - 10
SP - e0137062
JO - PLoS One
JF - PLoS One
IS - 8
ER -